Ryan Baker
About Ryan Baker
Ryan Baker serves as the Head of Investor Relations at KalVista Pharmaceuticals, Inc., bringing extensive experience in healthcare investment banking and biotechnology investor relations. He has previously held senior roles in investor relations at iTeos Therapeutics and Argot Partners, along with a long tenure at Cantor Fitzgerald & Co.
Current Role at KalVista Pharmaceuticals
Ryan Baker serves as the Head of Investor Relations at KalVista Pharmaceuticals, Inc., a position he has held since 2023. Located in Cambridge, Massachusetts, he is responsible for managing the company's communications with investors and stakeholders. His role involves articulating the company's strategic direction and financial performance to the investment community. His expertise in healthcare investment banking supports his efforts in fostering investor confidence and engagement.
Previous Experience in Investor Relations
Before joining KalVista Pharmaceuticals, Ryan Baker held significant roles in investor relations at various organizations. He was the Head of Investor Relations at iTeos Therapeutics from 2020 to 2023, where he focused on building relationships with investors. Prior to that, he served as Senior Vice President of Investor Relations at Argot Partners, LLC from 2018 to 2020. His experience also includes a 15-year tenure at Cantor Fitzgerald & Co. as Vice President of Institutional Equity Sales/Trading.
Educational Background
Ryan Baker studied at Boston College, where he earned a Bachelor of Arts (BA) degree in English Language and Literature. He also attended Delbarton School for his earlier education. His academic background has contributed to his communication skills, which are essential in his current role in investor relations.
Expertise in Biotechnology Investor Relations
Ryan Baker possesses specialized knowledge in biotechnology investor relations, particularly in oral, small molecule protease inhibitors. His understanding of this niche area enables him to effectively communicate complex scientific concepts to investors. Additionally, his skills in healthcare investment banking enhance his ability to navigate the intricacies of the biotechnology sector.
Skills in Securities Regulation and Trading Systems
Ryan Baker has a strong background in securities regulation and trading systems. This expertise is crucial for managing investor relations, as it allows him to ensure compliance with regulatory requirements while effectively communicating with stakeholders. His knowledge in this area supports his role in fostering transparent and informative investor communications.